Unique ID issued by UMIN | UMIN000006962 |
---|---|
Receipt number | R000008221 |
Scientific Title | Objective evaluation for changes of dopamine transporter using PET with [18F]FE-PE2I among psychiatric illnesses. |
Date of disclosure of the study information | 2012/01/01 |
Last modified on | 2018/07/02 10:37:14 |
Objective evaluation for changes of dopamine transporter using PET with [18F]FE-PE2I among psychiatric illnesses.
Evaluation for dopamine transporter using PET with [18F] FE-PE2I among psychiatric illnesses.
Objective evaluation for changes of dopamine transporter using PET with [18F]FE-PE2I among psychiatric illnesses.
Evaluation for dopamine transporter using PET with [18F] FE-PE2I among psychiatric illnesses.
Japan |
healthy adults, dementia with lewy body (DLB), schizophrenia, mood disorder, REM sleep behavior disorder (RBD), Attention deficit hyperactivity disorder (ADHD)
Neurology | Geriatrics | Psychiatry |
Adult |
Others
NO
To investigate the functional changes of dopamin transporter among DLB, Schizophrenia, mood disorder, RBD, ADHD, and healthy adults by PET with [18F] FE-PE2I
Others
To characterize the differences among DLB, Schizophrenia, mood disroder, RBD, ADHD, and healthy adults.
Quantitative measurement of brain dopamine transporter binding
brain MRI
Interventional
Parallel
Non-randomized
Open -no one is blinded
No treatment
6
Diagnosis
Device,equipment |
PET, MRI, neuropsychological batteries, neurological examinations
PET, MRI, neuropsychological batteries, neurological examinations
PET, MRI, neuropsychological batteries, neurological examinations
PET, MRI, neuropsychological batteries, neurological examinations
PET, MRI, neuropsychological batteries, neurological examinations
PET, MRI, neuropsychological batteries, neurological examinations
18 | years-old | <= |
90 | years-old | > |
Male and Female
Healthy adults
- without past or current history of psychiatric illnesses
illnesses groups
- who met the diagnostic criteria of DLB, Schizophrenia, Mood disorder, RBD, or ADHD
Exclusion criteria:
- With past or current history of serious medical illness and/or brain organic diseases
- Subject who is contraindicated for the use of MRI
- With past or current history of severe liver disease, kidney disease, heart disease, allergy, or severe drug allergy
- Subjects who are judged as not suitable for participation in this study
110
1st name | |
Middle name | |
Last name | Yoshiro Okubo, M.D., Ph.D. |
Nippon Medical School
Department of Neuropsychiatry
1-1-5 Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan
03-3822-2131
okubo-y@nms.ac.jp
1st name | |
Middle name | |
Last name | Amane Tateno, M.D., Ph.D. |
Nippon Medical School
Department of Neuropsychiatry
1-1-5 Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan
03-3822-2131
amtateno@nms.a.cjp
Nippon Medical School
Nippon Medical School
Self funding
NO
日本医科大学付属病院健診医療センター、日本医科大学付属病院、メディカルサテライト八重洲クリニック
2012 | Year | 01 | Month | 01 | Day |
Unpublished
Completed
2011 | Year | 12 | Month | 22 | Day |
2012 | Year | 01 | Month | 01 | Day |
2016 | Year | 03 | Month | 31 | Day |
2016 | Year | 09 | Month | 30 | Day |
2017 | Year | 03 | Month | 31 | Day |
2017 | Year | 06 | Month | 30 | Day |
2011 | Year | 12 | Month | 27 | Day |
2018 | Year | 07 | Month | 02 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008221
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |